Sigma Labs Inc. (SGLB)
NASDAQ: SGLB
· Real-Time Price · USD
1.05
0.02 (1.94%)
At close: May 19, 2022, 6:00 AM
Sigma Labs Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Nov 30, 2024 | Aug 31, 2024 | May 31, 2024 | Feb 29, 2024 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 15.38K | 102.01K | 36.68K | 323.81B | 9.28M | 11.45M | 13.06M | 14.73M | 16.84M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 38.42K | 45.17K | 45.17K | 42.17B | 978.98K | n/a | n/a | 793.47K | 788.37K |
Receivables | 1M | 1M | 1M | 1,000B | 261.02K | 412.19K | 666.74K | 389.45K | 388.05K |
Inventory | n/a | n/a | n/a | n/a | 782.1K | 710.08K | 856.55K | 847K | 747.78K |
Other Current Assets | 509.13K | 256.07K | 388.35K | 375B | 165.27K | 114.28K | 130.68K | 168.33K | 135.45K |
Total Current Assets | 1.52M | 1.36M | 1.43M | 1,698.8B | 10.49M | 12.68M | 14.72M | 16.14M | 18.11M |
Property-Plant & Equipment | 5.93K | 6.7K | 5.29K | 6.64B | 288.92K | 232.28K | 201.75K | 157.49K | 128.32K |
Goodwill & Intangibles | 3.41M | 3.48M | 3.22M | 3,341.2B | n/a | 925.11K | 868.26K | n/a | n/a |
Total Long-Term Assets | 3.45M | 3.53M | 3.27M | 3,390B | 1.27M | 1.16M | 1.07M | 950.96K | 916.69K |
Total Assets | 4.98M | 4.89M | 4.7M | 5,088.8B | 11.75M | 13.84M | 15.79M | 17.09M | 19.03M |
Account Payables | 1.33M | 1.15M | 972.87K | 531.85B | 320.55K | 206.44K | 223.16K | 315.77K | 280.44K |
Deferred Revenue | 90.2K | 138.07K | 154.2K | 139.92B | 160.28K | 148.85K | 85.48K | 63.57K | 76.42K |
Short-Term Debt | 6.76M | 2.86M | 1.75M | 828.28B | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | -1.79M | 880.59K | 654.24K | 460.77B | 416.64K | 625.94K | 432.62K | 184.1K | 5.12M |
Total Current Liabilities | 6.39M | 5.02M | 3.53M | 1,960.8B | 897.47K | 981.24K | 741.25K | 563.44K | 5.48M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | 480.82K | 355.3K | 93.53K | 93.53K | 93.53K |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | 480.82K | 355.3K | 131.25K | 131.25K | 131.25K |
Total Liabilities | 6.39M | 5.02M | 3.53M | 1,960.8B | 897.47K | 981.24K | 872.5K | 694.69K | 5.61M |
Total Debt | 6.76M | 2.86M | 1.75M | 828.28B | n/a | n/a | n/a | n/a | n/a |
Common Stock | 1.43K | 1.39K | 1.35K | 936M | 10.5K | 10.5K | 10.5K | 10.49K | 10.49K |
Retained Earnings | -29.71M | -27.69M | -26.14M | -24,151.1B | -42.81M | -40.59M | -38.18M | -35.68M | -33.82M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | -1.42M | -134.1K | 1.17M | 3,128B | 10.86M | 12.86M | 14.92M | 16.39M | 13.42M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |